Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 2
2010 3
2011 4
2012 6
2013 3
2014 5
2015 12
2016 13
2017 22
2018 21
2019 14
2020 11
2021 12
2022 13
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season.
Imran M, Puig-Barbera J, Ortiz JR, Lopez-Gonzalez L, Dean A, Bonafede M, Haag MDM. Imran M, et al. Among authors: ortiz jr. Influenza Other Respir Viruses. 2024 Apr;18(4):e13288. doi: 10.1111/irv.13288. Influenza Other Respir Viruses. 2024. PMID: 38644564 Free PMC article.
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022.
Fitzpatrick MC, Laufer RS, Baral R, Driscoll AJ, Feikin DR, Fleming JA, Jit M, Kim S, Koltai M, Li Y, Li X, Nair H, Neuzil KM, Pecenka C, Sparrow E, Srikantiah P, Ortiz JR. Fitzpatrick MC, et al. Among authors: ortiz jr. Vaccine. 2023 Nov 22;41(48):7047-7059. doi: 10.1016/j.vaccine.2023.09.040. Epub 2023 Sep 28. Vaccine. 2023. PMID: 37777450 Free PMC article.
Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18-64 Years During the 2019-2020 US Influenza Season.
Imran M, Puig-Barbera J, Ortiz JR, Lopez-Gonzalez L, Dean A, Bonafede M, Haag M. Imran M, et al. Among authors: ortiz jr. Open Forum Infect Dis. 2023 Jun 7;10(7):ofad304. doi: 10.1093/ofid/ofad304. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37496602 Free PMC article.
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.
El Sahly HM, Yildirim I, Frey SE, Winokur P, Jackson LA, Bernstein DI, Creech CB, Chen WH, Rupp RE, Whitaker JA, Phadke V, Hoft DF, Ince D, Brady RC, Edwards KM, Ortiz JR, Berman MA, Weiss J, Wegel A; DMID 17-0090 Study Group. El Sahly HM, et al. Among authors: ortiz jr. J Infect Dis. 2024 Feb 14;229(2):327-340. doi: 10.1093/infdis/jiad276. J Infect Dis. 2024. PMID: 37466221 Clinical Trial.
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Fleming JA, Baral R, Higgins D, Khan S, Kochar S, Li Y, Ortiz JR, Cherian T, Feikin D, Jit M, Karron RA, Limaye RJ, Marshall C, Munywoki PK, Nair H, Newhouse LC, Nyawanda BO, Pecenka C, Regan K, Srikantiah P, Wittenauer R, Zar HJ, Sparrow E. Fleming JA, et al. Among authors: ortiz jr. Vaccine. 2023 Nov 3;41 Suppl 2:S7-S40. doi: 10.1016/j.vaccine.2022.09.081. Epub 2023 Jul 6. Vaccine. 2023. PMID: 37422378 Free article.
Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network.
Andrew MK, Pott H, Staadegaard L, Paget J, Chaves SS, Ortiz JR, McCauley J, Bresee J, Nunes MC, Baumeister E, Raboni SM, Giamberardino HIG, McNeil SA, Gomez D, Zhang T, Vanhems P, Koul PA, Coulibaly D, Otieno NA, Dbaibo G, Almeida MLG, Laguna-Torres VA, Drăgănescu AC, Burtseva E, Sominina A, Danilenko D, Medić S, Diez-Domingo J, Lina B. Andrew MK, et al. Among authors: ortiz jr. Open Forum Infect Dis. 2023 May 7;10(6):ofad244. doi: 10.1093/ofid/ofad244. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37383245 Free PMC article.
Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.
Laufer RS, Baral R, Buchwald AG, Campbell JD, Coulibaly F, Diallo F, Doumbia M, Driscoll AJ, Galvani AP, Keita AM, Neuzil KM, Sow S, Pecenka C, Ortiz JR, Fitzpatrick MC. Laufer RS, et al. Among authors: ortiz jr. PLOS Glob Public Health. 2023 May 5;3(5):e0001432. doi: 10.1371/journal.pgph.0001432. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37145993 Free PMC article.
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.
Ortiz JR, Bernstein DI, Hoft DF, Woods CW, McClain MT, Frey SE, Brady RC, Bryant C, Wegel A, Frenck RW, Walter EB, Abate G, Williams SR, Atmar RL, Keitel WA, Rouphael N, Memoli MJ, Makhene MK, Roberts PC, Neuzil KM. Ortiz JR, et al. J Infect Dis. 2023 Aug 11;228(3):287-298. doi: 10.1093/infdis/jiad021. J Infect Dis. 2023. PMID: 36702771 Free PMC article.
144 results